Dr Kwok Yan

Experts / Dr Kwok Yan

Respiratory Physician

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

By Dr Kwok Yan

Videos

Drugs and devices, Respiratory and sleep

Dr Kwok Yan

Respiratory Physician

More from this expert

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

The NLCSP – Incidental chest findings – What now? – A focus on interstitial lung abnormalities

Tuesday 16th September, 7pm - 9pm AEST

Speaker

A/Prof Nicole Goh

Respiratory & Sleep Physician

We invite you to our next free webcast, where A/Prof Nicole Goh discusses the current state of play of the screening program and the likelihood of detecting non-lung cancer abnormalities. Earn up to 4 hours CPD. Accredited with RACGP and ACRRM.

Dr Kwok Yan

Respiratory Physician

More from this expert

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

The NLCSP – Incidental chest findings – What now? – A focus on interstitial lung abnormalities

Tuesday 16th September, 7pm - 9pm AEST

Speaker

A/Prof Nicole Goh

Respiratory & Sleep Physician

We invite you to our next free webcast, where A/Prof Nicole Goh discusses the current state of play of the screening program and the likelihood of detecting non-lung cancer abnormalities. Earn up to 4 hours CPD. Accredited with RACGP and ACRRM.